Explainable AI-Enhanced Kinase Activity Profiling Through Phosphoproteomics
Kinases play a critical role in regulating fundamental cellular processes, including metabolism, signal transduction, and cell growth, primarily through phosphorylation. The dysregulation of kinase activity is implicated in various diseases, highlighting the urgent need for robust and interpretable methodologies to profile this activity. Current approaches frequently depend on overly complex or limited datasets, lack generalizability, or fail to provide meaningful biological insights into the mechanisms governing kinase activity. To address these challenges, we developed an explainable deep learning framework that leverages mass spectrometry-based phosphoproteomics data to profile kinase activity effectively. Our study systematically evaluated deep neural networks (DNNs) and convolutional neural networks (CNNs), incorporating a diverse set of feature inputs, including phosphorylation sites and kinase-substrate relationships. A notable finding was that a three-layer CNN, optimized through rigorous feature selection techniques, demonstrated superior performance, achieving substantial improvements in prediction accuracy and stability when compared to established methods such as kinase-substrate enrichment analysis (KSEA) and the kinase activity ranking pipeline (KARP). We integrated Shapley additive explanations (SHAP) values to enhance interpretability, illuminating biologically significant phosphorylation sites. For example, PAK2-related phosphorylation sites associated with the progression of colon adenocarcinoma and CAMK2D sites integral to adrenergic signaling were identified, thereby effectively linking computational predictions to established molecular pathways. This research illustrates the potential of explainable artificial intelligence in advancing kinase activity profiling by providing accurate and interpretable predictions. Our framework is valuable for elucidating disease mechanisms and identifying therapeutic targets, facilitating broader applications in precision medicine.
Authors
- Justin Bo‐Kai Hsu
- Jorng‐Tzong Horng (ORCID: https://orcid.org/0000-0002-7671-0573)
- Ming-Feng Ho (ORCID: https://orcid.org/0000-0002-4457-890X)
- Chia‐Ru Chung (ORCID: https://orcid.org/0000-0002-4548-7620)
- Yun Tang (ORCID: https://orcid.org/0000-0002-8807-5239)
- Tzong-Yi Lee
- Li-Ching Wu
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Central University (TW)
- Yuan Ze University (TW)
Publication Details
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1109/cibcb66090.2025.11177112
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00